Gene therapy compositions and treatment of arrhythmia-induced right ventricular cardiomyopathy

摘要

Disclosed are compositions and methods for treating or preventing cardiomyopathy in a human subject. In some embodiments, the method comprises delivering a therapeutic dose of a gene therapy vector to cardiomyocytes of a human subject, wherein the gene therapy vector comprises a nucleic acid sequence encoding PKP2.